Disclosures for "Prospective Clinical Evolution in People with Prodromal Synucleinopathies"
-
Dr. Delva has received research support from Research Foundation - Flanders.
-
Dr. Fereshtehnejad has nothing to disclose.
-
The institution of Dr. Yao has received research support from NSERC-CD CREATE.
-
Ms. Pelletier has nothing to disclose.
-
The institution of Dr. Montplaisir has received research support from CIHR.
-
Dr. Gagnon has nothing to disclose.
-
Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.